China · Delayed Price · Currency is CNY Hualan Biological Vaccine Statistics
Total Valuation
SHE:301207 has a market cap or net worth of CNY 12.48 billion. The enterprise value is 9.41 billion.
| Market Cap | 12.48B |
| Enterprise Value | 9.41B |
Important Dates
The next estimated earnings date is Saturday, March 28, 2026.
| Earnings Date | Mar 28, 2026 |
| Ex-Dividend Date | Oct 27, 2025 |
Share Statistics
SHE:301207 has 595.00 million shares outstanding. The number of shares has decreased by -1.11% in one year.
| Current Share Class | 595.00M |
| Shares Outstanding | 595.00M |
| Shares Change (YoY) | -1.11% |
| Shares Change (QoQ) | +0.47% |
| Owned by Insiders (%) | 0.07% |
| Owned by Institutions (%) | 2.11% |
| Float | 80.02M |
Valuation Ratios
The trailing PE ratio is 177.16 and the forward PE ratio is 11.59.
| PE Ratio | 177.16 |
| Forward PE | 11.59 |
| PS Ratio | 12.78 |
| PB Ratio | 2.20 |
| P/TBV Ratio | 2.21 |
| P/FCF Ratio | 44.26 |
| P/OCF Ratio | 41.70 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 154.50, with an EV/FCF ratio of 33.36.
| EV / Earnings | 133.51 |
| EV / Sales | 9.63 |
| EV / EBITDA | 154.50 |
| EV / EBIT | n/a |
| EV / FCF | 33.36 |
Financial Position
The company has a current ratio of 3.26
| Current Ratio | 3.26 |
| Quick Ratio | 3.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -18.71 |
Financial Efficiency
Return on equity (ROE) is 1.20% and return on invested capital (ROIC) is -2.92%.
| Return on Equity (ROE) | 1.20% |
| Return on Assets (ROA) | -0.67% |
| Return on Invested Capital (ROIC) | -2.92% |
| Return on Capital Employed (ROCE) | -1.39% |
| Weighted Average Cost of Capital (WACC) | 9.01% |
| Revenue Per Employee | 1.31M |
| Profits Per Employee | 94,203 |
| Employee Count | 748 |
| Asset Turnover | 0.13 |
| Inventory Turnover | 1.13 |
Taxes
| Income Tax | -24.19M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +12.37% in the last 52 weeks. The beta is 0.87, so SHE:301207's price volatility has been lower than the market average.
| Beta (5Y) | 0.87 |
| 52-Week Price Change | +12.37% |
| 50-Day Moving Average | 20.47 |
| 200-Day Moving Average | 19.03 |
| Relative Strength Index (RSI) | 48.33 |
| Average Volume (20 Days) | 17,689,644 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301207 had revenue of CNY 976.44 million and earned 70.46 million in profits. Earnings per share was 0.12.
| Revenue | 976.44M |
| Gross Profit | 685.60M |
| Operating Income | -79.51M |
| Pretax Income | 46.27M |
| Net Income | 70.46M |
| EBITDA | 60.89M |
| EBIT | -79.51M |
| Earnings Per Share (EPS) | 0.12 |
Balance Sheet
The company has 3.08 billion in cash and n/a in debt, with a net cash position of 3.08 billion or 5.17 per share.
| Cash & Cash Equivalents | 3.08B |
| Total Debt | n/a |
| Net Cash | 3.08B |
| Net Cash Per Share | 5.17 |
| Equity (Book Value) | 5.67B |
| Book Value Per Share | 9.54 |
| Working Capital | 3.32B |
Cash Flow
In the last 12 months, operating cash flow was 299.36 million and capital expenditures -17.32 million, giving a free cash flow of 282.04 million.
| Operating Cash Flow | 299.36M |
| Capital Expenditures | -17.32M |
| Free Cash Flow | 282.04M |
| FCF Per Share | 0.47 |
Margins
Gross margin is 70.21%, with operating and profit margins of -8.14% and 7.22%.
| Gross Margin | 70.21% |
| Operating Margin | -8.14% |
| Pretax Margin | 4.74% |
| Profit Margin | 7.22% |
| EBITDA Margin | 6.24% |
| EBIT Margin | -8.14% |
| FCF Margin | 28.88% |
Dividends & Yields
This stock pays an annual dividend of 0.60, which amounts to a dividend yield of 2.86%.
| Dividend Per Share | 0.60 |
| Dividend Yield | 2.86% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 4 |
| Payout Ratio | 196.37% |
| Buyback Yield | 1.11% |
| Shareholder Yield | 3.96% |
| Earnings Yield | 0.56% |
| FCF Yield | 2.26% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 7, 2023. It was a forward split with a ratio of 1.5.
| Last Split Date | Jun 7, 2023 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
SHE:301207 has an Altman Z-Score of 5.34 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.34 |
| Piotroski F-Score | 4 |